Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3635012 | 0.84 | CYP2A6 (0.58) | TSHRCYP2A6CYP1A2ALDH1A1MAPK1 | |
| SCHEMBL24299848 | 0.81 | CYP2A6 (0.54) | TSHRCYP2A6CYP1A2ALDH1A1MAPK1 | |
| SCHEMBL16082559 | 0.80 | ALDH1A1 (0.54) | TSHRCYP2A6CYP1A2ALDH1A1MAPK1 | |
| SCHEMBL3420545 | 0.79 | CYP2A6 (0.52) | TSHRCYP2A6CYP1A2ALDH1A1MAPK1 | |
| SCHEMBL16067921 | 0.78 | ALDH1A1 (0.52) | TSHRCYP2A6CYP1A2ALDH1A1MAPK1 | |
| SCHEMBL30380487 | 0.78 | MAPT (0.67) | TSHRCYP2A6CYP1A2ALDH1A1MAPK1 | |
| SCHEMBL278576 | 0.78 | MAPT (0.67) | TSHRCYP2A6CYP1A2ALDH1A1MAPK1 | |
| SCHEMBL2200643 | 0.78 | HPGD (0.49) | TSHRCYP2A6ALDH1A1MAPK1KDM4E | |
| SCHEMBL13588225 | 0.78 | TSHR (0.50) | TSHRCYP2A6CYP1A2ALDH1A1MAPK1 | |
| SCHEMBL29955621 | 0.78 | HPGD (0.49) | TSHRCYP2A6ALDH1A1MAPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0247513-B1 | PROCESS FOR PRODUCING 2-METHYL-1,4-NAPHTHOQUINONE | Eisai Chemical Co., Ltd. (JP) | 1991-09-11 | — | — | EP | claimed |
| US-4906411-A | Process for producing 2-methyl-1,4-naphthoquinone | EISAI CHEMICAL CO., LTD. (JP) | 1990-03-06 | — | — | US | claimed |
| EP-0247513-A1 | Process for producing 2-methyl-1,4-naphthoquinone | Eisai Chemical Co., Ltd. (JP) | 1987-12-02 | — | — | EP | claimed |
| JP-9071887-A | — | — | None | — | — | JP | disclosed |
| JP-62294636-A | — | — | None | — | — | JP | disclosed |
| WO-2024005428-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2024-01-04 | — | — | WO | disclosed |
| WO-2023150374-A1 | INDUCERS OF KLF2 AND METHODS OF USE THEREOF | RIPARIAN PHARMACEUTICALS, INC. (US) | 2023-08-10 | — | — | WO | disclosed |
| CN-113171798-B | Heterogeneous iron catalyst, preparation method thereof and process for preparing 2-methyl-1, 4-naphthoquinone by catalysis | 南京工业大学 | 2023-07-07 | — | — | CN | disclosed |
| US-20230200209-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-11339182-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-05-24 | — | — | US | disclosed |
| US-20220123235-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-04-21 | — | — | US | disclosed |
| WO-2002057264-A1 | PYRROLE DERIVATES FOR TREATING CYTOKINE MEDIATED DISEASES | SANKYO COMPANY LIMITED (JP) | 2002-07-25 | — | — | WO | disclosed |
| EP-1070711-A2 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | Sankyo Company Limited (JP) | 2001-01-24 | — | — | EP | disclosed |
| JP-H0971887-A | PRODUCTION OF 2-METHYL-1,4-NAPHTHOQUINONE | SAKOTA KAGAKU KAIHATSU KENKYUSHO:KK | 1997-03-18 | — | — | JP | disclosed |
| US-5420362-A | Synthesis of 2-methyl-1-naphthol | CLAIROL, INC. (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0247513-B1 | PROCESS FOR PRODUCING 2-METHYL-1,4-NAPHTHOQUINONE | Eisai Chemical Co., Ltd. (JP) | 1991-09-11 | — | — | EP | disclosed |
| US-4906411-A | Process for producing 2-methyl-1,4-naphthoquinone | EISAI CHEMICAL CO., LTD. (JP) | 1990-03-06 | — | — | US | disclosed |
| JP-S62294636-A | PRODUCTION OF 2-METHYL-1,4-NAPHTHOQUINONE | EISAI CO LTD | 1987-12-22 | — | — | JP | disclosed |
| EP-0247513-A1 | Process for producing 2-methyl-1,4-naphthoquinone | Eisai Chemical Co., Ltd. (JP) | 1987-12-02 | — | — | EP | disclosed |
| US-4276305-A | INSECTICIDES, MITICIDES | HOFFMANN-LA ROCHE INC. (US) | 1981-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200209-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | CRY1, ZFX, PPOX | TSHR 2854/4885CYP2A6 982/4885CYP1A2 523/4885 |
| US-11339182-B2 | Organic electroluminescent materials and devices | CRY2, CRY1, CRYAA | TSHR 2355/4885CYP2A6 930/4885CYP1A2 481/4885 |
| US-20220123235-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RER1, OXSR1, C1R | TSHR 170/4885CYP2A6 3623/4885CYP1A2 2060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.